Opto Bio is developing miniaturised implants that are safe, effective, and minimally invasive. Opto believes that that the application of discreet, safe biological interfaces will enable remote and continuous neurological communication, changing the way we approach medicine by using the electrical language of the body. Advancing the frontiers of biological interfacing, Opto is using new electrical biomarkers that can be used to inform disease state in real time. Opto aims to improve patient outcomes and revolutionise precision treatment through their research, development, and clinical testing.
Opto Bio
Deep Tech, Human Computer Interface / Europe, England / Pre-seed